HK Doctors Prefer Chinese Covid Vaccine: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1571820_1_20210122181304.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.htm', 'DCS.dcsqry', '' ); } } }); }); });

2021-01-22 HKT 16:18

Share this story

facebook

  • HK doctors prefer Chinese Covid vaccine: survey

A pro-government healthcare workers' group and four unions in the medical sector say a survey they've carried out suggests Hong Kong doctors, nurses and dentists prefer China's Sinovac coronavirus jabs to those developed overseas.

Medical Conscience said on Friday that they polled 930 healthcare workers, including 444 doctors and 318 dentists, regarding the three vaccines the Hong Kong government has procured so far.

Sixty-one percent said their preferred vaccine would be the one made by Sinovac, while 22 percent opted for the one made by Germany's BioNTech and 11 percent the jab from Anglo-Swedish company AstraZeneca.

Five percent of the respondents said they would refuse to take Covid-19 vaccines altogether.

Medical Conscience said the survey was carried out between January 7 and January 14.

Researchers in Brazil only made public the findings of their late-stage trials of the Sinovac jabs on January 13, saying it has an efficacy rate of 50.4 percent - lower than those of the other two.

But Dr David Lam from Medical Conscience said many in the medical sector already knew that Sinovac was their favourite, because it is made in a more conventional way, using inactivated virus particles.

"Maybe doctors and nurses are kind of more conservative people so they choose something they know well. That’s probably the reason why more people chose the inactivated virus technology," Lam said at a press conference.

"I wouldn’t really put too much emphasis on the branding of the vaccines, but rather the technology behind them."

Lam also said he has no problem with the government’s plan to prioritise care home residents and staff over healthcare workers when the inoculation programme is launched.

He said while he believes doctors and nurses should be among the first groups of people to get the jabs, they don't need to be right at the front of the queue because they are well-trained and can protect themselves using their professional knowledge.

RECENT NEWS

Hong Kong Launches Smart Seniors Anti-Scam Ambassador Programme To Protect The Elderly

The Hong Kong Monetary Authority (HKMA) and the Hong Kong Association of Banks (HKAB) jointly organised the launch cere... Read more

Payment Connect Sees Active Participation In Cross-Boundary Remittances

The People’s Bank of China (PBoC) and the Hong Kong Monetary Authority (HKMA) officially launched Payment Connect on ... Read more

GoTyme Hong Kong Is Entering The Scene With Flexible Financing

GoTyme Hong Kong, which is part of the GoTyme Merchant Cash Advance (MCA) Asia business line under Tyme Group, announce... Read more

BGE Is Hong Kongs Latest Licensed Virtual Asset Trading Platform

Hong Kong BGE Limited (BGE) has secured its license to operate as a virtual asset trading platform (VATP) as of 17 June... Read more

China Backs Digital Yuan And Promotes Multi-Polar Currency System

The head of China’s central bank has promised to boost the global adoption of the digital yuan and called for the dev... Read more

JD Targets Stablecoin Licenses In Multiple Markets For Faster Payments

JD.com plans to secure stablecoin licenses in a series of major markets, founder Richard Liu announced at a Beijing pre... Read more